Mission
Genechron srl is a biotech company that operates in the medical diagnostics sector. Genechron offers molecular genetics services on genes involved in the susceptibility to the development of cancer, in the response to pharmacological therapies and in the onset of hereditary pathologies or metabolic alterations. Furthermore, it carries out qualitative and quantitative analysis of microorganisms or viral agents. A peculiar characteristic of Genechron is the ability to provide specialized scientific and diagnostic support to healthcare facilities and research institutions throughout the national territory.
Genechron was born as an innovative start-up in 2016, taking over the biotech technologies of the “Genechron laboratory” of the Ylichron company, with the aim of further developing lines of research and services in the clinical field.
Genechron has highly specialized staff who have been working in the field of molecular biology and genetics for over 10 years, and uses modern and advanced instrumental equipment.
The company avails itself of a Scientific Advisory Board made up of prominent personalities from the world of Research and Clinical Medicine.
Management
Staff
Investors
Genechron is a company founded in 2016 to further develop the biotechnology activities initiated within Ylichron Srl (an ENEA spin-off) and to give them a market-driven boost. Ylichron Srl, founded in 2005, initially focused strongly on the application of high-performance computing (HPC) techniques in research and industrial sectors. In 2009, the company entered the biotechnology field, which increasingly required the integration of computational services. In addition to bioinformatics services, Ylichron began providing advanced biotechnology services, including DNA sequencing using Sanger and NGS methods.
As the biotechnology area experienced significant growth, Ylichron decided to spin off its biotechnology services, incorporating and enhancing them within a new company called Genechron Srl, which is entirely focused on biotechnology and has retained the strong commitment to innovation of its parent company. Genechron Srl has acquired new shareholders through investment rounds that enabled the entry of public and private investors; among them is Lazio Innova SpA, an in-house company of the Lazio Region dedicated to providing financial support to the region’s industrial sectors, acting in its role as a venture capital investor.
Genechron’s Business Plan, in addition to planning substantial growth in the medical diagnostics area (through authorization as a Specialized Medical Genetics Laboratory by the Lazio Region), is strongly oriented toward the discovery and development of innovative assays for the quantification of RNA biomarkers, for both diagnostic and pharmaceutical applications.
Certifications
ISO9001:2015 certification
Genechron has been certified ISO9001:2015 by Bureau Veritas Italia S.p.A. as Genechron’s management system has been evaluated and found to comply with the requirements of the management system standard in the field of molecular genetics and laboratory diagnostic services.
For further information, consult the certificate and the QR code contained in it.
From Research to Advanced Health Care Diagnostics
CONTACT US WITHOUT COMMITMENT WITH THE METHOD YOU PREFER
+39.06.5036729
info@genechron.com
